Gene · 8661
Papers4,269
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 4,269
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Complement factor H attenuates TNF-α-induced inflammation by upregulating EIF3C in rheumatoid arthritis. | J Transl Med | 2023 | 37996918 | PubTator, text mining | PubMed |
| Circular RNAs in renal cell carcinoma: from mechanistic to clinical perspective. | Cancer Cell Int | 2023 | 37993909 | PubTator, text mining | PubMed |
| Pediatric HIV+ Kaposi sarcoma exhibits clinical, virological, and molecular features different from the adult disease. | JCI Insight | 2023 | 37991023 | PubTator, text mining | PubMed |
| Advances and key focus areas in gastric cancer immunotherapy: A comprehensive scientometric and clinical trial review (1999-2023). | World J Gastroenterol | 2023 | 37970478 | PubTator, text mining | PubMed |
| Insights into the regulatory role of RNA methylation modifications in glioma. | J Transl Med | 2023 | 37964279 | PubTator, text mining | PubMed |
| Early enterovirus translation deficits extend viral RNA replication and elicit sustained MDA5-directed innate signaling. | mBio | 2023 | 37962360 | PubTator, text mining | PubMed |
| m5U-GEPred: prediction of RNA 5-methyluridine sites based on sequence-derived and graph embedding features. | Front Microbiol | 2023 | 37937221 | PubTator, text mining | PubMed |
| Correlation between HER2/neu protein overexpression on Immunohistochemistry and Fluorescent in Situ Hybridization (FISH) in breast carcinoma: Problems in developing countries. | Pak J Med Sci | 2023 | 37936749 | PubTator, text mining | PubMed |
| Significance of RNA N6-methyladenosine regulators in the diagnosis and subtype classification of coronary heart disease using the Gene Expression Omnibus database. | Front Cardiovasc Med | 2023 | 37928762 | PubTator, text mining | PubMed |
| Regulatory role of RNA modifications in the treatment of pancreatic ductal adenocarcinoma (PDAC). | Heliyon | 2023 | 37928039 | PubTator, text mining | PubMed |
| Characterizing the extracellular vesicle proteomic landscape of the human airway using in vitro organotypic multi-cellular models. | iScience | 2023 | 37920665 | PubTator, text mining | PubMed |
| The regulation of antiviral innate immunity through non-m6A RNA modifications. | Front Immunol | 2023 | 37915585 | PubTator, text mining | PubMed |
| The emerging roles of N6-methyladenosine RNA modifications in thyroid cancer. | Eur J Med Res | 2023 | 37915103 | PubTator, text mining | PubMed |
| A comprehensive prognostic score for head and neck squamous cancer driver genes and phenotype traits. | Discov Oncol | 2023 | 37897503 | PubTator, text mining | PubMed |
| In Vitro Transcribed RNA-Based Platform Vaccines: Past, Present, and Future. | Vaccines (Basel) | 2023 | 37897003 | PubTator, text mining | PubMed |
| RNA-based translation activators for targeted gene upregulation. | Nat Commun | 2023 | 37884512 | PubTator, text mining | PubMed |
| Circular RNAs: biology and clinical significance of breast cancer. | RNA Biol | 2023 | 37882644 | PubTator, text mining | PubMed |
| ZNF692 organizes a hub specialized in 40S ribosomal subunit maturation enhancing translation in rapidly proliferating cells. | Cell Rep | 2023 | 37851577 | PubTator, text mining | PubMed |
| Crosstalk between m6A modification and alternative splicing during cancer progression. | Clin Transl Med | 2023 | 37850412 | PubTator, text mining | PubMed |
| Cellular signaling modulated by miRNA-3652 in ovarian cancer: unveiling mechanistic pathways for future therapeutic strategies. | Cell Commun Signal | 2023 | 37845675 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8661/papers?page=11